跳至主要内容
临床试验/NCT00598286
NCT00598286已完成1 期

Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2

National Institute of Mental Health (NIMH)1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2008年1月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
18
试验地点
1
主要终点
Efficacy of novel PET tracer for CB1 in brain imaging.

研究概览

简要总结

The purpose of this protocol is to measure brain CB1 receptors in the hope to better understand how they work, so that one day we can understand how the CB1 receptors are involved in psychiatric, neurological, and behavioral disorders.

详细描述

BRAIN IMAGING

Objective

The central cannabinoid receptor (CB1) is one of the most abundant neuromodulatory receptors in the brain. It is found on glutamatergic, dopaminergic and GABA-ergic synaptic terminals and belongs to G-protein coupled receptor family. The CB1 is a target for drug therapy, including the use of an antagonist as an appetite suppressant. The central cannabinoid receptor CB1 has never been visualized in humans. In collaboration with Eli Lilly, we developed a promising PET ligand for the CB1 receptor: [18F]FMPEP-d2 ((3R,5R)-5-(3-(fluoromethoxy)phenyl)-3-((R)-1-phenylethylamino)-1-(4-(trifluoromethyl)phenyl)pyrrolidin-2-one).

Study Population

In the current protocol, we wish to evaluate [18F]FMPEP-d2 in approximately 10 healthy subjects.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •INCLUSION CRITERIA:
  • •All subjects must be healthy and aged 18-65 years, with history/physical exam, ECG, and laboratory tests within one year of the PET scan.
  • •The volunteer must sign an informed consent form.

排除标准

  • •Current psychiatric illness, substance abuse including marijuana use, or severe systemic disease based on history and physical exam.
  • •Laboratory tests with clinically significant abnormalities or positive urine toxicology screen.
  • •Prior participation in other research protocols in the last year such that radiation exposure would exceed the annual limits.
  • •Pregnancy and breast feeding.
  • •Claustrophobia.
  • •Presence of ferromagnetic metal in the body or heart pacemaker.
  • •Positive HIV test.
  • •Employee of the investigative site or an immediate family member of an employee of the investigative site. Immediate family member is defined as a spouse, parent, child, or sibling, whether biological or legally adopted.
  • •Employee of Eli Lilly and Company.

结局指标

主要结局

Efficacy of novel PET tracer for CB1 in brain imaging.

次要结局

  • Distribution and variance of CB1 receptors in the brain of healthy controls.

研究者

研究点 (1)

Loading locations...

相似试验